Impact of Alcohol on the Onset and Progression of Alzheimers Disease and Its Related Dementias (R01- Clinical Trial Optional) (RFA-AA-20-006)
GRANT Monday, November 18, 2019- 07:00 National Institute on Alcohol Abuse and Alcoholism National Institute on Aging Issuing IC and partner components intend to commit an estimated total of $3 million to fund six to eight awards. March 24, 2020 Impact of ...
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) (RFA-NS-19-043)
GRANT Monday, November 18, 2019- 07:00 National Institutes of Health The BRAIN Initiative intends to commit $4.0M per year in fiscal years 2020-2023 to fund an estimate of 20 awards per year. New February 10, 2020, June 10, 2020, October 9, 2020; February 10, ...
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) (RFA-NS-19-044)
GRANT Monday, November 18, 2019- 07:00 National Institutes of Health The BRAIN Initiative intends to commit $4.0M per year in fiscal years 2020-2023 to fund an estimate of 20 awards per year. New February 10, 2020; June 10, 2020; October 9, 2020; February 10, ...
University of Wisconsin - MadisonMadison, United States
PAPER Tripathi MK, Rasheed MS, Mishra AK, Patel DK, Singh MP
Silymarin Protects Against Impaired Autophagy Associated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinsonism.J Mol Neurosci. 2019 Nov 15; PubMed: 31732923
PAPER Zhou Z, Müller ML, Kanel P, Chua J, Kotagal V, Kaufer DI, Albin RL, Frey KA, Bohnen NI
Apathy rating scores and β-amyloidopathy in Parkinson disease patients at risk for cognitive decline.Neurology. 2019 Nov 15; PubMed: 31732566
PAPER Charidimou A, Boulouis G, Greenberg SM, Viswanathan A31732564
PAPER Bernardo TC, Beleza J, Rizo-Roca D, Santos-Alves E, Leal C, Martins MJ, Ascensão A, Magalhães J31733314
PAPER Esmaeili MH, Enayati M, Khabbaz Abkenar F, Ebrahimian F, Salari AA
Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease.Behav Brain Res. 2020 Feb 3;379:112359. Epub 2019 Nov 13 PubMed: 31733313
PAPER Lee J, Hamanaka G, Lo EH, Arai K31733036
PAPER Katayama T, Sawada J, Kikuchi-Takeguchi S, Kano K, Takahashi K, Saito T, Okizaki A, Hasebe N
Cerebrospinal fluid levels of alpha-synuclein, amyloid β, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclearNeurosci Lett. 2020 Jan 10;715:134564. Epub 2019 Nov 13 PubMed: 31733322
PAPER Wang R, Yang Y, Wang H, He Y, Li C
MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1.Clin Exp Pharmacol Physiol. 2019 Nov 15; PubMed: 31732967
PAPER Dong B, Wu R
Plasma homocysteine, folate and vitamin B12 levels in Parkinson's disease in China: A meta-analysis.Clin Neurol Neurosurg. 2020 Jan;188:105587. Epub 2019 Nov 4 PubMed: 31733593
PAPER Olasehinde TA, Olaniran AO, Okoh AI